Related Experiment Video
Updated: Jul 13, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Role of cerebral microbleeds in acute ischemic stroke and atrial fibrillation
Meng Wang1, Yuyuan Yang1, Moxin Luan1
1Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, 266001, Shandong, China.
Abstract:
Cerebral microbleeds (CMBs) are commonly detected in the brains of patients with acute ischemic stroke (AIS). With the development of neuroimaging, clinicians are paying more attention to the presence of CMBs. CMBs were found to significantly increase the risk of intracranial hemorrhagic transformation and hemorrhage in patients with AIS, especially in patients with concurrent atrial fibrillation (AF). Additionally, the presence of CMBs is thought to be a symbol of a high risk of recurrent ischemic stroke (IS). A few researchers have found that the presence of CMBs has no significant effect on the prognosis of patients with AIS. Therefore, the current views on the role of CMBs in the prognoses of patients with IS are controversial. The use of anticoagulants and other drugs has also become a dilemma due to the special influence of CMBs on the prognosis of these patients. Due to the large number of patients with AF and CMBs, many studies have been conducted on the effects of CMBs on these patients and subsequent pharmacological treatments. However, at present, there are no relevant guidelines to guide the secondary preventive treatment of patients with stroke, CMBs, and AF. In this paper, we summarized the role of CMBs in AIS combined with AF and relevant preventive measures against the recurrence of stroke and the occurrence of intracerebral hemorrhage to help clarify the specifics of drug therapies for this group of patients.
Insights
Cerebral microbleeds (CMBs) increase risks in acute ischemic stroke (AIS) patients, especially with atrial fibrillation (AF). This review clarifies CMBs
Area of Science:
- Neurology
- Neuroimaging
- Cardiology
Background:
- Cerebral microbleeds (CMBs) are increasingly detected in acute ischemic stroke (AIS) patients via advanced neuroimaging.
- CMBs significantly elevate risks of hemorrhagic transformation and intracranial hemorrhage in AIS, particularly when co-occurring with atrial fibrillation (AF).
- The prognostic impact of CMBs in AIS remains controversial, with some studies indicating no significant effect on patient outcomes.
Purpose of the Study:
- To review the role of CMBs in AIS patients with concurrent AF.
- To summarize preventive strategies against recurrent stroke and intracerebral hemorrhage in this population.
- To clarify drug therapies for patients with AIS, CMBs, and AF, addressing current guideline gaps.
Main Methods:
- Literature review of studies on cerebral microbleeds in acute ischemic stroke.
- Analysis of the association between CMBs and outcomes in patients with atrial fibrillation.
- Synthesis of evidence regarding secondary stroke prevention and hemorrhage risk management.
Main Results:
- CMBs are associated with increased hemorrhagic risk and potentially recurrent stroke in AIS patients, especially those with AF.
- Controversy exists regarding CMBs' impact on AIS prognosis.
- Current treatment guidelines lack specific recommendations for managing anticoagulation in patients with AIS, CMBs, and AF.
Conclusions:
- Cerebral microbleeds present complex challenges in managing acute ischemic stroke patients with atrial fibrillation.
- Further research and clear guidelines are needed for optimal secondary prevention and pharmacological treatment in this high-risk group.
- Understanding CMBs' role is crucial for tailoring treatments to reduce stroke recurrence and hemorrhage risk.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

